Welcome to the Hawaii Chapter of the American College of Cardiology


2026 Conference
Click here to learn about our annual Chapter meeting April 25, 2026
Click here to download the flyer

ACC Live Courses
For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings


RSS Latest in Cardiology from ACC.org

  • ERAS-Based Signaling in Cardiology Fellowship Recruitment
    A recent JACC review explores the growing impact of Electronic Residency Application Service (ERAS)-based signaling in cardiology fellowship recruitment, highlighting the most recent data, areas of future investigation, and practical guidance for applicants and programs.
  • HHS Releases Consumer Alert on Fraudulent CV Testing Schemes
    The U.S. Department of Health and Human Services' (HHS') Office of Inspector General has issued a consumer alert, urging parents, caregivers, athletic programs and student athletes to beware of fraudulent cardiovascular testing schemes exploiting fears around sudden cardiac arrest in young athletes.
  • Combined LDL-C, Lp(a) and hsCRP Assessment Identifies Long-Term Risk of ASCVD
    Combined assessment of LDL-C, Lp(a) and hsCRP reflected independent pathways for identifying individuals of varied ethnicities at greater long-term risk of atherosclerotic cardiovascular disease (ASCVD), according to an analysis of the HELIUS cohort published June 24 in JACC.
  • 2026 Mid-Year Update on ACC Advocacy Efforts
    Throughout the first half of 2026, ACC’s Advocacy Team has been actively engaged in shaping policy at both the federal and state levels and working with policymakers to support cardiovascular clinicians and improve patient care nationwide. Read about key highlights from this work below.
  • New Risk Score Helps Identify Bleeding Risk With DOACs in Cancer-Associated VTE
    The novel ONCO-DOAC BLEED risk score, developed by Tomoyuki Nagai, MD, et al., provided clinically relevant major bleeding risk stratification for patients with cancer-associated venous thromboembolism (VTE) receiving direct oral anticoagulants (DOAC), according to research published June 16 in JACC: CardioOncology.